Israeli Jews

OurCrowd Announces Winners of Second Annual Maimonides Award for Lifetime Achievement at 2019 Global Investor Summit

Retrieved on: 
Thursday, March 7, 2019
Technology, Other Technology, Health, Alternative medicine, Research, Other Science, Science, OurCrowd, Science and technology in Israel, Drugs, Economy, Israeli Jews, Raphael Mechoulam, Tetrahydrocannabinol, Startup company, Cannabinoid, Avraham

OurCrowd , a leading global investment platform and Israels most active venture investor, announced today Professor Raphael Mechoulam and Professor Avraham Baniel as the winners of the second annual OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit*.

Key Points: 
  • OurCrowd , a leading global investment platform and Israels most active venture investor, announced today Professor Raphael Mechoulam and Professor Avraham Baniel as the winners of the second annual OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit*.
  • His contributions of over 50 years of research include the isolation and synthesis of THC and the identification of the endocannabinoid system.
  • This announcement was made at the 2019 OurCrowd Global Investor Summit in Jerusalem, the largest technology showcase in Israel with over 170 startups and 17,000 registered attendees.
  • About the 2019 OurCrowd Global Investor Summit:The OurCrowd Global Investor Summit, Where the startup world gathers.

The 150th Patient in CartiHeal's Pivotal Study Was Operated on in Tel Aviv, Israel

Retrieved on: 
Thursday, March 7, 2019
Biomedical engineering, Implant, Prosthetics, Tissue engineering, Biological engineering, Israeli Jews

Guy Morag, Head of the Sports Medicine Unit at Tel Aviv's Sourasky (Ichilov) Medical Center and Team Physician of the Maccabi Tel Aviv Basketball Club.

Key Points: 
  • Guy Morag, Head of the Sports Medicine Unit at Tel Aviv's Sourasky (Ichilov) Medical Center and Team Physician of the Maccabi Tel Aviv Basketball Club.
  • CartiHeal's pivotal IDE study is ongoing in the US, EU, and Israel.
  • We hope this important study will demonstrate the superiority of the Agili-C implant over the current surgical practice," said Dr. Morag.
  • CartiHeal, a privately-held medical device company headquartered in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.

Cutting-Edge Heart Treatment Now in the United States and Israel for Medical Trials

Retrieved on: 
Wednesday, March 6, 2019
Sheba Medical Center, Medical physics, Radiation therapy, Tel HaShomer, Israeli Jews, Physical sciences, Academic disciplines, Health

There is now a noninvasive treatment option that saves lives and provides better outcomes for heart patients.

Key Points: 
  • There is now a noninvasive treatment option that saves lives and provides better outcomes for heart patients.
  • Using this new procedure, physicians can directly target damaged heart tissue and restore the heart back to a safe and healthy rhythm.
  • at Israel's Sheba Medical Center, Tel HaShomer , say the radiation treatment is a game-changer.
  • Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East.

Israel's Most Innovative Medical Powerhouse Opens South Florida Office

Retrieved on: 
Tuesday, February 19, 2019
Sheba Medical Center, Tel HaShomer, Cities in Israel, Israeli Jews

HOLLYWOOD, Fla., Feb. 19, 2019 /PRNewswire-PRWeb/ --American Friends of Sheba Medical Center, Tel HaShomer today announced a new office in South Florida to help raise awareness and support for Israel's national hospital, Sheba Medical Center, Tel HaShomer.

Key Points: 
  • HOLLYWOOD, Fla., Feb. 19, 2019 /PRNewswire-PRWeb/ --American Friends of Sheba Medical Center, Tel HaShomer today announced a new office in South Florida to help raise awareness and support for Israel's national hospital, Sheba Medical Center, Tel HaShomer.
  • "If you live in South Florida and are interested in the most innovative advances in healthcare and medical research, then I urge you to learn about Sheba Medical Center, Tel HaShomer," added Dr. David Pulver, a longtime Sheba donor who lives in Aventura.
  • To lead the new South Florida division, American Friends of Sheba Medical Center has named Alan Frent to serve as South Florida regional director.
  • Frent plans to recruit a cross-section of the South Florida community to form an American Friends of Sheba Medical Center Advisory Committee.

CannaTech Tel Aviv 2019: Israel's Premier International Summit for Accelerating Cannabis Innovation

Retrieved on: 
Tuesday, February 19, 2019
Tel Aviv, UNESCO Creative Cities Network, Israeli Jews, Footballers

The main events will take place at Trask, in the Tel Aviv Port on the Mediterranean Sea from April 1-3, 2019.

Key Points: 
  • The main events will take place at Trask, in the Tel Aviv Port on the Mediterranean Sea from April 1-3, 2019.
  • To learn more about the CannaTech Tel Aviv Innovation Summit, purchase tickets and subscribe to event updates and speakers lists click here .
  • iCAN is committed to accelerate Israel's Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market.
  • iCAN is powered by CannaTech, the premier international cannabis summit held annually in Tel Aviv, and around the world including London, Sydney, Hong Kong and Panama to date and Europe and Africa in 2019.

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

Retrieved on: 
Friday, February 15, 2019
Articles, Health sciences, Learned societies, Israeli Jews, Avram Hershko, Paul L. Modrich, Pharmacogenomics, Forensic science, Technion – Israel Institute of Technology, American Academy of Forensic Sciences

The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.

Key Points: 
  • The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.
  • Three Nobel Lectures will be given by prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Paul Modrich (Duke University).
  • During ISABS 2019 Conference we will envision the power and advances of personalized medicine that will createsignificantvalue for the healthcare system.
  • International Society for Applied Biological Sciences (ISABS) is the Association of the American Academy of Forensic Sciences and a leading society in forensic, anthropologicgenetics and personalized medicine.

Mattel And MGM Partner To Produce Live Action Motion Picture Based On Iconic American Girl® Brand

Retrieved on: 
Friday, February 15, 2019
Toys, Businesspeople, Mattel, Israeli Jews, Barbie, El Segundo, California, Ynon Kreiz, American Girl, Doll

LOS ANGELES, Feb. 15, 2019 /PRNewswire/ --Mattel, Inc.(NASDAQ: MAT) and Metro Goldwyn Mayer Pictures (MGM) have partnered to develop a live action motion picture based on Mattel's classic American Girl line of books and dolls.

Key Points: 
  • LOS ANGELES, Feb. 15, 2019 /PRNewswire/ --Mattel, Inc.(NASDAQ: MAT) and Metro Goldwyn Mayer Pictures (MGM) have partnered to develop a live action motion picture based on Mattel's classic American Girl line of books and dolls.
  • Over 32 million American Girl dolls and 157 million American Girl books have been sold through the company's catalogue, retail stores and website to date.
  • Ynon Kreiz,Mattel'sChairman and CEO said: "American Girl is a beloved, story-driven franchise lending itself perfectly to a feature film.
  • "American Girl is a timeless and iconic brand that is part of the fabric of families all over the world.

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

Retrieved on: 
Friday, February 15, 2019
Science and technology in Israel, Israeli Jews, Science, Health, Avram Hershko, Paul L. Modrich, Technion – Israel Institute of Technology, Pharmacogenomics, Forensic science, American Academy of Forensic Sciences, Max Planck Society

The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.

Key Points: 
  • The Conference is supported by The American Academy for Forensic Sciences and conference topics include: personalized and regenerative medicine, pharmacogenomics, molecular diagnostics, stem cell therapy, epigenetics, biobanking, microbiome, cancer genetics, immunotherapy, forensic and anthropological genetics, ancient DNA analysis, etc.
  • Three Nobel Lectures will be given by prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Paul Modrich (Duke University).
  • During ISABS 2019 Conference we will envision the power and advances of personalized medicine that will createsignificantvalue for the healthcare system.
  • International Society for Applied Biological Sciences (ISABS) is the Association of the American Academy of Forensic Sciences and a leading society in forensic, anthropologicgenetics and personalized medicine.

TAL Education Group Acquires Ready4

Retrieved on: 
Thursday, February 7, 2019
Ready4, TAL, New York Stock Exchange, Tel Aviv, Economy of the United States, Service companies, Israeli Jews, Education

BOSTON, Feb. 7, 2019 /PRNewswire/ --NYSE-listed, Beijing-headquartered leading educational service company TAL Education Group (TAL) has acquired Boston-Tel Aviv mobile-first and AI-powered online test preparation and admissions services startup company Ready4, Inc. (formerly known as LTG Exam Prep Platform, Inc.).

Key Points: 
  • BOSTON, Feb. 7, 2019 /PRNewswire/ --NYSE-listed, Beijing-headquartered leading educational service company TAL Education Group (TAL) has acquired Boston-Tel Aviv mobile-first and AI-powered online test preparation and admissions services startup company Ready4, Inc. (formerly known as LTG Exam Prep Platform, Inc.).
  • With the completion of the deal today, we are excited to fully bring Ready4 into TAL family."
  • TAL Education Group is well-positioned to provide our offering at a larger scale.
  • Ready4 has been supported by leading investors including Square Peg Capital and TAL Education Group (NYSE: TAL).

Sage Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 19, 2019

Retrieved on: 
Tuesday, February 5, 2019
Health, Biotechnology, Mental health, Pharmaceutical, Israeli Jews

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the company will host a conference call and live webcast on Tuesday, February 19, 2019 at 8:00 a.m. EST to report its fourth quarter and full year 2018 financial results and to discuss recent business updates.

Key Points: 
  • Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the company will host a conference call and live webcast on Tuesday, February 19, 2019 at 8:00 a.m. EST to report its fourth quarter and full year 2018 financial results and to discuss recent business updates.
  • The live webcast can be accessed on the investor page of Sage's website at investor.sagerx.com.
  • The conference call can be accessed by dialing 1-866-450-8683 (toll-free domestic) or 1-281-542-4847 (international) and using the conference ID 6968949.
  • Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering CNS disorders.